atorvastatin has been researched along with Coronary Stenosis in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 14 (60.87) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Ha, K; Han, SH; Jang, AY; Kang, WC; Kim, M; Lee, K; Moon, J; Oh, PC; Suh, SY | 1 |
| Adamova, IYU; Afanasieva, OI; Balakhonova, TV; Ezhov, MV; Konovalov, GA; Matchin, YG; Pokrovsky, SN; Safarova, MS | 1 |
| Bible, PW; Guo, F; Guo, M; Liu, J; Shi, D; Shi, J; Tian, Y; Wang, C; Wang, P; Wei, L; Yang, M | 1 |
| Akturk, E; Altas, Y; Atas, H; Balta, S; Can, C; Demirkol, S; Erdem, K; Korkmaz, H; Kurtoglu, E; Sincer, I; Yilmaz, M | 1 |
| Brener, SJ; Hu, T; Ivanc, TB | 1 |
| Fujii, T; Kunita, E; Maeda, K; Sekiguchi, Y; Tasaki, N; Tsujiyama, S; Urabe, Y | 1 |
| Ahmed, K; Ahn, Y; Cho, JG; Cho, SH; Choi, YH; Hachinohe, D; Hong, YJ; Hwang, SH; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Ko, JS; Lee, MG; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS | 1 |
| Sillence, D; Tchan, M | 1 |
| Ghosh, AK; Kumar, KK; Kumar, KV; Prusty, P | 1 |
| Adamova, IY; Afanasieva, OI; Atanesyan, RV; Ezhov, MV; Konovalov, GA; Matchin, YG; Pokrovsky, SN; Safarova, MS; Utkina, EA | 1 |
| Ashby, DT; Conditt, G; Dangas, G; Hirose, M | 1 |
| Bavendiek, U; Ganz, P; Gerdes, N; Horton, DB; Kinlay, S; Libby, P; Reynolds, RS; Robbie, L; Schönbeck, U; Varo, N | 1 |
| Fathi, R; Haluska, B; Marwick, TH; Short, L | 1 |
| Di Sciascio, G; Nusca, A; Pasceri, V; Patti, G; Pristipino, C; Richichi, G | 1 |
| Berger, PB; Hennekens, CH; Lowry, DR; Malinin, AI; Midei, MG; O'Connor, CM; Oshrine, BR; Sane, DC; Serebruany, VL; Steinhubl, SR; Tanguay, JF | 1 |
| Deac, R; Dobreanu, M; Gălăţeanu, C; Simionescu, A | 1 |
| Fujita, H; Fujiwara, H; Ito, Y; Kawasaki, M; Minatoguchi, S; Murata, I; Okubo, M; Sano, K; Tsuchiya, K; Yokoyama, H; Zhou, X | 1 |
| Altinbas, A; Aslan, SM; Dede, O; Dogan, A; Ozaydin, M; Ozturk, M; Turker, Y; Varol, E | 1 |
| Kuryata, OV; Yegorova, YV | 1 |
| Kawamura, A; Mitsutake, R; Miura, S; Niimura, H; Okamura, K; Saku, K | 1 |
| Gawaz, M; Geisler, T; Paterok, M; Zürn, CS | 1 |
| Cooper, A; Kratzer, S; Pershad, A | 1 |
| Libby, P | 1 |
10 trial(s) available for atorvastatin and Coronary Stenosis
| Article | Year |
|---|---|
Effect of Atorvastatin (10 mg) and Ezetimibe (10 mg) Combination Compared to Atorvastatin (40 mg) Alone on Coronary Atherosclerosis.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Coronary Artery Disease; Coronary Stenosis; Drug Therapy, Combination; Ezetimibe; Female; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Severity of Illness Index; Spectroscopy, Near-Infrared; Ultrasonography, Interventional | 2021 |
Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
Topics: Atorvastatin; Biomarkers; Blood Component Removal; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lipoprotein(a); Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2017 |
Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.
Topics: Arginine; Atorvastatin; Biomarkers; Coronary Angiography; Coronary Stenosis; Down-Regulation; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Time Factors; Treatment Outcome; Turkey | 2014 |
Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Topics: Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Disease Progression; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Korea; Male; Plaque, Atherosclerotic; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.
Topics: Adult; Atorvastatin; Biomarkers; Blood Component Removal; Chi-Square Distribution; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Disease Progression; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoprotein(a); Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrroles; Russia; Time Factors; Treatment Outcome | 2013 |
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
Topics: Animals; Atorvastatin; Blood Coagulation; CD40 Antigens; CD40 Ligand; Cells, Cultured; Cohort Studies; Coronary Stenosis; Cytokines; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes, Mononuclear; Lipoproteins, LDL; Male; Mice; Middle Aged; Muscle, Smooth, Vascular; Phagocytes; Pyridines; Pyrroles; RNA, Messenger; Simvastatin | 2002 |
A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention.
Topics: Angina Pectoris; Anticholesteremic Agents; Atorvastatin; Brachial Artery; Carotid Arteries; Cholesterol, LDL; Coronary Artery Disease; Coronary Stenosis; Echocardiography, Stress; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles; Surveys and Questionnaires; Vascular Resistance | 2003 |
Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Atorvastatin; Biomarkers; Coronary Stenosis; Creatine Kinase; Creatine Kinase, MB Form; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Myoglobin; Premedication; Prospective Studies; Pyrroles; Stents; Treatment Outcome; Troponin I | 2004 |
Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound.
Topics: Aged; Atorvastatin; Coronary Stenosis; Drug Administration Schedule; Echocardiography, Three-Dimensional; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pravastatin; Pyrroles; Reproducibility of Results; Ultrasonography, Interventional | 2005 |
Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Atorvastatin; C-Reactive Protein; Chronotherapy; Coronary Restenosis; Coronary Stenosis; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pyrroles; Treatment Outcome | 2006 |
13 other study(ies) available for atorvastatin and Coronary Stenosis
| Article | Year |
|---|---|
Panax Quinquefolium Saponins Attenuate Myocardial Dysfunction Induced by Chronic Ischemia.
Topics: Animals; Arterioles; Atorvastatin; Chromatography, High Pressure Liquid; Chronic Disease; Coronary Stenosis; Down-Regulation; Echocardiography; Glucose; Heart; Mass Spectrometry; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Proteome; Proteomics; Saponins; Swine; Up-Regulation; Ventricular Function | 2018 |
The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Disease Progression; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Male; Middle Aged; Pravastatin; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ultrasonography, Interventional | 2008 |
Coronary plaque stabilization followed by Color Code Plaque analysis with 64-slice multidetector row computed tomography.
Topics: Anticholesteremic Agents; Atorvastatin; Coronary Angiography; Coronary Stenosis; Coronary Vasospasm; Diabetes Complications; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hypertension; Middle Aged; Pyrroles; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defibrillators, Implantable; Drug Therapy, Combination; Enzyme Replacement Therapy; Fabry Disease; Factor V; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metoprolol; Middle Aged; Perindopril; Pyrroles; Quality of Life; Recurrence; Sequence Deletion; Stents; Stroke; Stroke Rehabilitation; Thrombophilia; Warfarin | 2011 |
Tendinous xanthoma.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol; Coronary Angiography; Coronary Stenosis; Echocardiography; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Middle Aged; Pyrroles; Stents; Tendons; Treatment Outcome; Xanthomatosis | 2012 |
Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD.
Topics: Adult; Aspirin; Atorvastatin; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Isosorbide; Pyrroles; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Ultrasonography, Interventional | 2002 |
Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Blood Platelets; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Stenosis; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Pyrroles; Stents; Ticlopidine | 2004 |
Effects of Atorvastatin on some inflammatory parameters in severe primary hypercholesterolemia.
Topics: Adult; Atorvastatin; Biomarkers; Coronary Stenosis; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrroles | 2002 |
The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Coronary Stenosis; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hyperlipidemias; Male; Middle Aged; Pyrroles | 2006 |
Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography.
Topics: Adult; Angina Pectoris; Anticholesteremic Agents; Atorvastatin; Coronary Artery Disease; Coronary Stenosis; Follow-Up Studies; Heptanoic Acids; Humans; Male; Pyrroles; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[Influence of statins on the antiplatelet effect of clopidogrel and on cardiovascular outcome in patients after coronary intervention].
Topics: Atorvastatin; Clopidogrel; Coronary Disease; Coronary Stenosis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Stents; Ticlopidine | 2008 |
Coronary revascularization and aggressive lipid lowering.
Topics: Aspirin; Atorvastatin; Coronary Stenosis; Heptanoic Acids; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Metoprolol; Middle Aged; Myocardial Revascularization; Plasminogen Activators; Pyrroles; Risk Factors | 1999 |
What have we learned about the biology of atherosclerosis? The role of inflammation.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cholesterol, Dietary; Coronary Artery Disease; Coronary Stenosis; Heptanoic Acids; Humans; Inflammation Mediators; Pyrroles; Rabbits | 2001 |